Latest filing published 01 Oct 2019 for Myriad Genetics INC, €62k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +30.0%Entry US$21.43 · Close at T+365 US$27.85
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Ralph L. McDade: trading record in brief
All filings by Ralph L. McDade on record concern Myriad Genetics Inc. Over a trading history stretching from 17 September 2014 to 30 September 2019, the count stands at 22 filings.
On the open market, the record shows 1 purchase worth €19k and 1 sale worth €54k. Netting one side against the other leaves €35k of net selling. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 7 share grants. In 2019 alone, the filings show no purchases and 1 sale.
On 1 October 2019 came the latest disclosure, a transaction for €62k in Myriad Genetics Inc. The clock since the last published purchase (15 August 2016) now reads 3,738 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Ralph L. McDade
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,361 shares@ US$28.637.8% of flowCommon StockSEC:0001594674-19-000006:0
- 2,952 shares@ US$28.639.7% of flowCommon StockSEC:0001594674-19-000006:1
- 30,000 shares0Common StockSEC:0001594674-19-000004:2
- 2,657 shares@ US$29.939.1% of flowCommon StockSEC:0001594674-19-000004:0
- 2,952 shares@ US$29.9310.1% of flowCommon StockSEC:0001594674-19-000004:1
- 1,975 shares@ US$31.006.8% of flowCommon StockSEC:0001594674-19-000002:0
- 2,361 shares@ US$46.0010.2% of flowCommon StockSEC:0001594674-18-000008:0
- 2,952 shares@ US$46.0012.8% of flowCommon StockSEC:0001594674-18-000008:1
- 2,952 shares@ US$46.6512.8% of flowCommon StockSEC:0001594674-18-000006:0
- 27,000 shares0Common StockSEC:0001594674-18-000004:0
- 3,148 shares@ US$46.3513.7% of flowCommon StockSEC:0001594674-18-000002:0
- 1,641 shares@ US$36.184.7% of flowCommon StockSEC:0001594674-17-000006:0
- 2,052 shares@ US$36.185.9% of flowCommon StockSEC:0001594674-17-000006:1
- 2,188 shares@ US$33.055.7% of flowCommon StockSEC:0001594674-17-000004:0
- 30,000 shares0Common StockSEC:0001594674-17-000002:0
- 1,641 shares@ US$20.582.8% of flowCommon StockSEC:0001594674-16-000019:0
- 2,188 shares@ US$20.923.8% of flowCommon StockSEC:0001594674-16-000017:0
- 30,000 shares0Common StockSEC:0001594674-16-000015:0
- 1,000 shares@ US$21.491.8% of flowCommon StockSEC:0001594674-16-000013:0Canonical exit: 10 Nov 2016 (T+90)
- 24,000 shares0Common StockSEC:0001594674-15-000011:0
- 2,188 shares@ US$41.39Common StockSEC:0001594674-15-000011:1
- 32,000 shares0Common StockSEC:0001594674-14-000004:0
22 of 22 declarations
